Many drugs that could provide effective treatments for terminally ill patients take years to be approved. I recently supported legislation that would allow patients with an advanced illness access to these experimental drugs.
Senate Bill 991 creates the “Right to Try Act,” which would let patients use investigational drugs, biological products or devices that have not yet been approved for general use by the U.S. Food and Drug Administration (FDA). To be eligible for new treatments and medicine, a patient must have:
- An advanced illness attested to by the treating physician;
- Considered all other available treatment options;
- Received a recommendation from their physician to try an investigational drug, biological product or device;
- Given written informed consent; and
- Documentation from their physician that the patient meets all the requirements.
The legislation has been referred to the House Health Policy Committee.